Use of Calcium Channel Blockers and Parkinson’s Disease – Medscape News

Experimental evidence and case-control studies suggest that dihydropyridine calcium channel blockers (DiCCBs) may protect against Parkinson’s disease. The authors conducted a historical cohort study in Denmark to investigate the association …

Leave a Reply

Your email address will not be published. Required fields are marked *